US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Tsumura and Company (PK) (TSMRF) 銘柄情報

Tsumura and Company (PK) (TSMRF)

23.20

0.00

(0.00%)

終了 6月14日 5:00AM

Tsumura and Company (PK) (TSMRF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

23.20

( - )

買値

15.74

売値

523.25

出来高

-

0.00 日の範囲 0.00

23.20 52 週間の範囲 25.75

時価総額

前日終値

23.20

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 305,685

発行済株式数

74,545,456

配当利回り

147

PER

9.83

1 株当たり利益 (EPS)

376.28

歳入

192.62B

純利益

28.12B

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as wel... Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.tsumura.co.jp

本社

Tokyo, Japan

設立

1893

Tsumura and Company (PK) is listed in the Healthcare sector of the その他OTC with ticker TSMRF. The last closing price for Tsumura (PK) was US$23.20. Over the last year, Tsumura (PK) shares have traded in a share price range of US$ 23.20 to US$ 25.75.

Tsumura (PK) currently has 74,545,456 shares in issue. The market capitalisation of Tsumura (PK) is US$1.73 billion. Tsumura (PK) has a price to earnings ratio (PE ratio) of 9.83.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	23.2	23.2	23.2	0	0	CS
26	0	0	23.2	23.2	23.2	0	0	CS
52	-0.5383	-2.26764342855	23.7383	25.75	23.2	43	24.07514444	CS
156	3.83	19.7728446051	19.37	28.15	18.1	113	24.79482988	CS
260	-7.45	-24.3066884176	30.65	31.62	18.1	128	25.83047297	CS

TSMRF - Frequently Asked Questions (FAQ)

What is the current Tsumura and Company (PK) share price?

The current share price of Tsumura and Company (PK) is US$ 23.20

How many Tsumura and Company (PK) shares are in issue?

Tsumura and Company (PK) has 74,545,456 shares in issue

What is the market cap of Tsumura and Company (PK)?

The market capitalisation of Tsumura and Company (PK) is USD 1.73B

What is the 1 year trading range for Tsumura and Company (PK) share price?

Tsumura and Company (PK) has traded in the range of US$ 23.20 to US$ 25.75 during the past year

What is the PE ratio of Tsumura and Company (PK)?

The price to earnings ratio of Tsumura and Company (PK) is 9.83

What is the cash to sales ratio of Tsumura and Company (PK)?

The cash to sales ratio of Tsumura and Company (PK) is 1.43

What is the registered address of Tsumura and Company (PK)?

The registered address for Tsumura and Company (PK) is 2-17-11, Akasaka, Tokyo, 107-8521

What is the Tsumura and Company (PK) website address?

The website address for Tsumura and Company (PK) is www.tsumura.co.jp

Which industry sector does Tsumura and Company (PK) operate in?

Tsumura and Company (PK) operates in the Pharmaceuticals sector

joe_techi

joe_techi 11分前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 21分前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 27分前

Is july going to be IBATs Month?

rodeoup

rodeoup 1時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 1時間前

please send me the email

satter

satter 2時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 2時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 2時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 2時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 3時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 3時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 3時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 3時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 3時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 4時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 4時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

europa7

europa7 4時間前

Dell’s $10b DoD Deal Adds Support To AI Infrastructure Story
June 3, 2026
https://finance.yahoo.com/markets/stocks/articles/dell-10b-dod-deal-adds-070959172.html
***
***
Pentagon Deal Triggers Speculation — Could Dell Bring Hedera Into Federal Systems?
30 Ma

norisknorewards

norisknorewards 4時間前

What a great post with an overload of common sense!!!!

Go NWBO!!!

JD400

JD400 4時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

sam1933

sam1933 4時間前

The next trillion transactions won’t come from humans.

They’ll come from satellites, sensors, machines, and AI agents interacting autonomously.

https://x.com/CreusMoreira/status/2064583073526616219

JD400

JD400 4時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

SDCRBS

SDCRBS 4時間前

Hardlesson, IMO, I think Melvin has done a good job in this area. Could he be more aggressive, Sure! One thing for sure though, He does not pump the stock unnecessarily and I believe that he has a plan that will have a lasting effect, not a temporary bump. He has a goal of uplisting and IMO that i

Just give me $1.50

Just give me $1.50 4時間前

LOL.

You mean $720 million .

- "IQVIA reported annual sales for the twelve months ending June 2023 of $720 million for the brand and generic market for this product."

https://elite.irpass.com/Elite-Pharmaceuticals-Files-ANDA-with-US-FDA-to-Market-Opiate-

Bank of Montreal Point t...

Amundi Floating Rate Usd...

Matrix AI Network

Lions Bay Capital

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。